Hantz Financial Services, Inc. Tonix Pharmaceuticals Holding Corp. Transaction History

Hantz Financial Services, Inc.

  • $5.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 06, 2024
BUY
$0.46 - $1.3 $10,649 - $30,095
23,150 Added 37.02%
85,690 $51,000
Q4 2022

Aug 06, 2024
BUY
$0.29 - $0.57 $13,339 - $26,219
46,000 Added 278.11%
62,540 $24,000
Q3 2022

Aug 06, 2024
BUY
$0.53 - $1.9 $2,915 - $10,450
5,500 Added 49.82%
16,540 $9,000
Q2 2022

Aug 06, 2024
BUY
$1.58 - $7.36 $17,443 - $81,254
11,040 New
11,040 $17,000

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email